White Shield

Interest-Based Ads

Advertising Cookies: We would like to set third-party advertising cookies on your browser for this health-related website to help us serve relevant health-related advertisements to you about our products or services when you visit other websites. For more information, visit our Privacy Policy. Do you want to set these advertising cookies on this browser?

FIND A TREATMENT SITE
Patients HCP
This site is for US residents only.
Patient advocate Luke explains what LUTATHERA is.

LUTATHERA early can help slow NET progression for longer

Target icon

LUTATHERA delivers targeted radiation to NETs

Slow icon

LUTATHERA was proven to slow progression for longer:

  • In patients with recently diagnosed, faster-growing 
    NETs (Ki-67, 10%–55% [grade 2 or 3])
  • In people with NETs that progressed on SSA

What is LUTATHERA ?

 

NETs, neuroendocrine tumors; SSA, somatostatin analogue.